IPC issues alert against adverse reactions of painkiller Meftal, Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com

In a recent drug safety advisory, the Indian Pharmacopoeia Commission (IPC) advised consumers and healthcare providers to keep an eye out for any negative side effects from the painkiller Meftal, which is frequently prescribed for rheumatoid arthritis and menstrual cramps., In a recent drug safety advisory, the Indian Pharmacopoeia Commission (IPC) advised consumers and healthcare providers to keep an eye out for any negative side effects from the painkiller Meftal, which is frequently prescribed for rheumatoid arthritis and menstrual cramps., , Read More